跳至主要内容
临床试验/JPRN-jRCTs051220167
JPRN-jRCTs051220167招募中2 期

A randomized trial to evaluate the nutritional support with ISOCAL CLEAR and rehabilitation on prevention of skeletal muscle mass loss -a pilot study

Kiyoshi Maeda0 个研究点目标入组 40 人开始时间: 2023年2月13日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • (1)Histologically proven squamous cell carcinoma, adenosquamous carcinoma, or basaloid cell carcinoma.
  • (2)Stage II-III
  • (3)Aged 20 years and older.
  • (4)ECOG Performance status 0 or 1.
  • (5)oral intake is possible
  • (6)Major organ function is preserved.
  • (7)Witten informed consent is obtained.

排除标准

  • (1)Simultaneous or metachronous (within 5 years) double cancers , with the exception of intramucosal tumor curable with local therapy.
  • (2)Active infection requiring systemic therapy.
  • (3)Fever over 38 degrees Celsius
  • (4)Female during pregnancy, within 28 days of postparturition, or during lactation. Male who wants partner's pregnancy.
  • (5)Psychological disorder difficult to participate in this clinical study.
  • (6)Diabetes mellitus uncontrollable with continuous use of insuline or hypoglycemic agents.
  • (7)Severe emphysema, interstitial pneumonia or pulmonary fibrosis based on chest CT.
  • (8)Uncontrolled arterial hypertension.
  • (9)Drug history of opioids, or stroids.
  • (10)History of unstable angina pectoris within three weeks or myocardial infarction within six months before registration.
  • (11) Allergy for milk (or protein from milk)
  • (12) Other reason why principal investigator considered ineligible

研究者

发起方
Kiyoshi Maeda

相似试验